A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study.

A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study.

Item
http://www.wikidata.org/entity/Q33364897
Recent advances in targeted therapy for Ewing sarcomaDiagnosis and treatment of Ewing sarcoma of the bone: a review articleMarine pharmacology in 2005-2006: antitumour and cytotoxic compounds.Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growthTrabectedin: the evidence for its place in therapy in the treatment of soft tissue sarcoma.Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investmentA phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumorsA phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies.Phase I and Phase II Objective Response Rates are Correlated in Pediatric Cancer Trials: An Argument for Better Clinical Trial EfficiencyMetastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report.Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics.Bone sarcomas: from biology to targeted therapies.Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus.Advances in the Treatment of Pediatric Bone Sarcomas.
P2860

A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study.

Item
http://www.wikidata.org/entity/Q33364897
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A phase I and pharmacokinetic ...... ildren's Oncology Group study.
@ast
A phase I and pharmacokinetic ...... ildren's Oncology Group study.
@en
type
label
A phase I and pharmacokinetic ...... ildren's Oncology Group study.
@ast
A phase I and pharmacokinetic ...... ildren's Oncology Group study.
@en
prefLabel
A phase I and pharmacokinetic ...... ildren's Oncology Group study.
@ast
A phase I and pharmacokinetic ...... ildren's Oncology Group study.
@en
P1433
P1476
P2093
P304
P31
P407
P433
P478
P50
P577
P698
P1433
P1476
A phase I and pharmacokinetic ...... ildren's Oncology Group study.
@en
P2093
P304
P31
P407
P433
P478
P50
P577
P698